Keywords
Hepatitis E Virus HEV Elimination Control Blood Transfusion Transmission WHO Viral Hepatitis
References
-
1.
World Health Organization. Combating hepatitis B and C to reach elimination by 2030. 2016. World Health Organization; 2020.
-
2.
Pourkarim MR, Razavi H, Lemey P, Van Ranst M. Iran's hepatitis elimination programme is under threat. Lancet. 2018;392(10152):1009. [PubMed ID: 30264697]. https://doi.org/10.1016/S0140-6736(18)31810-5.
-
3.
Thijssen M, Lemey P, Amini-Bavil-Olyaee S, Dellicour S, Alavian SM, Tacke F, et al. Mass migration to Europe: an opportunity for elimination of hepatitis B virus? Lancet Gastroenterol Hepatol. 2019;4(4):315-23. [PubMed ID: 30860067]. https://doi.org/10.1016/S2468-1253(19)30014-7.
-
4.
Pourkarim MR, Van Ranst M. Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon. 2011;11(10):783-5. [PubMed ID: 22224075]. [PubMed Central ID: PMC3234578]. https://doi.org/10.5812/kowsar.1735143X.773.
-
5.
Sonderup MW, Spearman CW. Global Disparities in Hepatitis B Elimination-A Focus on Africa. Viruses. 2022;14(1). [PubMed ID: 35062286]. [PubMed Central ID: PMC8777803]. https://doi.org/10.3390/v14010082.
-
6.
Murali AR, Kotwal V, Chawla S. Chronic hepatitis E: A brief review. World J Hepatol. 2015;7(19):2194-201. [PubMed ID: 26380044]. [PubMed Central ID: PMC4561773]. https://doi.org/10.4254/wjh.v7.i19.2194.
-
7.
Wallace SJ, Swann R, Donnelly M, Kemp L, Guaci J, Murray A, et al. Mortality and morbidity of locally acquired hepatitis E in the national Scottish cohort: a multicentre retrospective study. Aliment Pharmacol Ther. 2020;51(10):974-86. [PubMed ID: 32285976]. https://doi.org/10.1111/apt.15704.
-
8.
Pourkarim MR, Vergote V, Amini-Bavil-Olyaee S, Sharifi Z, Sijmons S, Lemey P, et al. Molecular characterization of hepatitis B virus (HBV) strains circulating in the northern coast of the Persian Gulf and its comparison with worldwide distribution of HBV subgenotype D1. J Med Virol. 2014;86(5):745-57. [PubMed ID: 24532489]. https://doi.org/10.1002/jmv.23864.
-
9.
Elsadek Fakhr A, Pourkarim MR, Maes P, Atta AH, Marei A, Azab M, et al. Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt. Hepat Mon. 2013;13(12). e12706. [PubMed ID: 24358038]. [PubMed Central ID: PMC3867025]. https://doi.org/10.5812/hepatmon.12706.
-
10.
Li P, Liu J, Li Y, Su J, Ma Z, Bramer WM, et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int. 2020;40(7):1516-28. [PubMed ID: 32281721]. [PubMed Central ID: PMC7384095]. https://doi.org/10.1111/liv.14468.
-
11.
Khuroo MS, Khuroo MS, Khuroo NS. Hepatitis E: Discovery, global impact, control and cure. World J Gastroenterol. 2016;22(31):7030-45. [PubMed ID: 27610014]. [PubMed Central ID: PMC4988308]. https://doi.org/10.3748/wjg.v22.i31.7030.
-
12.
Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: What we know so far? World J Gastroenterol. 2022;28(1):47-75. [PubMed ID: 35125819]. [PubMed Central ID: PMC8793017]. https://doi.org/10.3748/wjg.v28.i1.47.
-
13.
Saiada F, Rahman HNA, Moni S, Karim MM, Pourkarim MR, Azim T, et al. Clinical presentation and molecular characterization of group B rotaviruses in diarrhoea patients in Bangladesh. J Med Microbiol. 2011;60(Pt 4):529-36. [PubMed ID: 21183601]. https://doi.org/10.1099/jmm.0.025981-0.
-
14.
Nahar S, Afrad MH, Begum N, Al-Mamun F, Sarker AK, Das SK, et al. High prevalence of noroviruses among hospitalized diarrheal patients in Bangladesh, 2011. J Infect Dev Ctries. 2013;7(11):892-6. [PubMed ID: 24240050]. https://doi.org/10.3855/jidc.2944.
-
15.
Tahaei SM, Mohebbi SR, Zali MR. Enteric hepatitis viruses. Gastroenterol Hepatol Bed Bench. 2012;5(1):7-15. [PubMed ID: 24834192]. [PubMed Central ID: PMC4017450].
-
16.
Villalba R, Mirabet V. Risk assessment of hepatitis E transmission through tissue allografts. World J Gastrointest Pathophysiol. 2022;13(2):50-8. [PubMed ID: 35433096]. [PubMed Central ID: PMC8976234]. https://doi.org/10.4291/wjgp.v13.i2.50.
-
17.
Khuroo MS, Kamili S, Khuroo MS. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat. 2009;16(7):519-23. [PubMed ID: 19228284]. https://doi.org/10.1111/j.1365-2893.2009.01101.x.
-
18.
Jilani N, Das BC, Husain SA, Baweja UK, Chattopadhya D, Gupta RK, et al. Hepatitis E virus infection and fulminant hepatic failure during pregnancy. J Gastroenterol Hepatol. 2007;22(5):676-82. [PubMed ID: 17444855]. https://doi.org/10.1111/j.1440-1746.2007.04913.x.
-
19.
Kar P, Jilani N, Husain SA, Pasha ST, Anand R, Rai A, et al. Does hepatitis E viral load and genotypes influence the final outcome of acute liver failure during pregnancy? Am J Gastroenterol. 2008;103(10):2495-501. [PubMed ID: 18785952]. https://doi.org/10.1111/j.1572-0241.2008.02032.x.
-
20.
Kar P, Sengupta A. A guide to the management of hepatitis E infection during pregnancy. Expert Rev Gastroenterol Hepatol. 2019;13(3):205-11. [PubMed ID: 30791760]. https://doi.org/10.1080/17474124.2019.1568869.
-
21.
Zhang M, Li G, Shang J, Pan C, Zhang M, Yin Z, et al. Rapidly decreased HBV RNA predicts responses of pegylated interferons in HBeAg-positive patients: a longitudinal cohort study. Hepatol Int. 2020;14(2):212-24. [PubMed ID: 32100261]. [PubMed Central ID: PMC7136184]. https://doi.org/10.1007/s12072-020-10015-3.
-
22.
Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis e in heart transplant recipients. Am J Transplant. 2012;12(11):3128-33. [PubMed ID: 22823202]. https://doi.org/10.1111/j.1600-6143.2012.04200.x.
-
23.
Dreier J, Knabbe C, Vollmer T. Transfusion-Transmitted Hepatitis E: NAT Screening of Blood Donations and Infectious Dose. Front Med (Lausanne). 2018;5:5. [PubMed ID: 29450199]. [PubMed Central ID: PMC5799287]. https://doi.org/10.3389/fmed.2018.00005.
-
24.
Pourkarim M, Hajiani GR, Khamisipour GR, Ardeshirdavani N, Tahmasebi R. [Seroepidemiological investigation of HTLV I, II infection among Busherian multi-transfused patients in 2003]. Blood. 2005;2(4). Persian.
-
25.
Slavov SN, Maconetto JDM, Martinez EZ, Silva-Pinto AC, Covas DT, Eis-Hubinger AM, et al. Prevalence of hepatitis E virus infection in multiple transfused Brazilian patients with thalassemia and sickle cell disease. J Med Virol. 2019;91(9):1693-7. [PubMed ID: 31066064]. https://doi.org/10.1002/jmv.25498.
-
26.
Poukarim MR, Khamisipour G, Zandi K, Roustaee MH. [Prevalence of anti-HTLV-I & anti-HTLV-II antibodies in blood donors in Bushehr province]. ISMJ. 2004;6(2):161-4. Persian.
-
27.
Corman VM, Drexler JF, Eckerle I, Roth WK, Drosten C, Eis-Hubinger AM. Zoonotic hepatitis E virus strains in German blood donors. Vox Sang. 2013;104(2):179-80. [PubMed ID: 22913247]. https://doi.org/10.1111/j.1423-0410.2012.01638.x.
-
28.
Thijssen M, Devos T, Ejtahed HS, Amini-Bavil-Olyaee S, Pourfathollah AA, Pourkarim MR. Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases. Microorganisms. 2020;8(11). [PubMed ID: 33167389]. [PubMed Central ID: PMC7694357]. https://doi.org/10.3390/microorganisms8111733.
-
29.
Baylis SA, Gartner T, Nick S, Ovemyr J, Blumel J. Occurrence of hepatitis E virus RNA in plasma donations from Sweden, Germany and the United States. Vox Sang. 2012;103(1):89-90. [PubMed ID: 22220775]. https://doi.org/10.1111/j.1423-0410.2011.01583.x.
-
30.
Reuter G, Fodor D, Forgach P, Katai A, Szucs G. Characterization and zoonotic potential of endemic hepatitis E virus (HEV) strains in humans and animals in Hungary. J Clin Virol. 2009;44(4):277-81. [PubMed ID: 19217346]. https://doi.org/10.1016/j.jcv.2009.01.008.
-
31.
Domanovic D, Tedder R, Blumel J, Zaaijer H, Gallian P, Niederhauser C, et al. Hepatitis E and blood donation safety in selected European countries: a shift to screening? Euro Surveill. 2017;22(16). [PubMed ID: 28449730]. [PubMed Central ID: PMC5404480]. https://doi.org/10.2807/1560-7917.ES.2017.22.16.30514.
-
32.
de Vos AS, Janssen MP, Zaaijer HL, Hogema BM. Cost-effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands. Transfusion. 2017;57(2):258-66. [PubMed ID: 28144956]. https://doi.org/10.1111/trf.13978.
-
33.
Kamp C, Blumel J, Baylis SA, Bekeredjian-Ding I, Chudy M, Heiden M, et al. Impact of hepatitis E virus testing on the safety of blood components in Germany - results of a simulation study. Vox Sang. 2018;113(8):811-3. [PubMed ID: 30318777]. https://doi.org/10.1111/vox.12719.
-
34.
Amini-Bavil-Olyaee S, Pourkarim MR, Schaefer S, Mahboudi F, Van Ranst M, Adeli A, et al. Single-step real-time PCR to quantify hepatitis B virus and distinguish genotype D from non-D genotypes. J Viral Hepat. 2011;18(4):300-4. [PubMed ID: 20367802]. https://doi.org/10.1111/j.1365-2893.2010.01308.x.
-
35.
Ganova-Raeva L, Punkova L, Campo DS, Dimitrova Z, Skums P, Vu NH, et al. Cryptic Hepatitis B and E in Patients With Acute Hepatitis of Unknown Etiology. J Infect Dis. 2015;212(12):1962-9. [PubMed ID: 26155829]. https://doi.org/10.1093/infdis/jiv315.
-
36.
Cuypers L, Thijssen M, Shakibzadeh A, Sabahi F, Ravanshad M, Pourkarim MR. Next-generation sequencing for the clinical management of hepatitis C virus infections: does one test fits all purposes? Crit Rev Clin Lab Sci. 2019;56(6):420-34. [PubMed ID: 31317801]. https://doi.org/10.1080/10408363.2019.1637394.
-
37.
Withenshaw SM, Grierson SS, Smith RP. Study of Animal Mixing and the Dynamics of Hepatitis E Virus Infection on a Farrow-to-Finish Pig Farm. Animals (Basel). 2022;12(3). [PubMed ID: 35158596]. [PubMed Central ID: PMC8833537]. https://doi.org/10.3390/ani12030272.
-
38.
Watts N, Amann M, Arnell N, Ayeb-Karlsson S, Belesova K, Berry H, et al. The 2018 report of the Lancet Countdown on health and climate change: shaping the health of nations for centuries to come. Lancet. 2018;392(10163):2479-514. [PubMed ID: 30503045]. https://doi.org/10.1016/S0140-6736(18)32594-7.
-
39.
Pourkarim MR, Thijssen M, Alavian SM, Van Ranst M. Natural disasters pose a challenge for hepatitis elimination in Iran. Lancet Gastroenterol Hepatol. 2019;4(8):581-2. [PubMed ID: 31292070]. https://doi.org/10.1016/S2468-1253(19)30197-9.
-
40.
Primadharsini PP, Nagashima S, Okamoto H. Mechanism of Cross-Species Transmission, Adaptive Evolution and Pathogenesis of Hepatitis E Virus. Viruses. 2021;13(5). [PubMed ID: 34069006]. [PubMed Central ID: PMC8157021]. https://doi.org/10.3390/v13050909.
-
41.
Meng XJ. Novel strains of hepatitis E virus identified from humans and other animal species: is hepatitis E a zoonosis? J Hepatol. 2000;33(5):842-5. [PubMed ID: 11097496]. https://doi.org/10.1016/s0168-8278(00)80319-0.
-
42.
Zhang W, Ami Y, Suzaki Y, Doan YH, Muramatsu M, Li TC. Mongolia Gerbils Are Broadly Susceptible to Hepatitis E Virus. Viruses. 2022;14(6). [PubMed ID: 35746596]. [PubMed Central ID: PMC9229706]. https://doi.org/10.3390/v14061125.
-
43.
Kupke P, Werner JM. Hepatitis E Virus Infection-Immune Responses to an Underestimated Global Threat. Cells. 2021;10(9). [PubMed ID: 34571931]. [PubMed Central ID: PMC8468229]. https://doi.org/10.3390/cells10092281.
-
44.
Pourkarim M, Nayebzadeh S, Alavian SM, Hataminasab SH. Digital Marketing: A Unique Multidisciplinary Approach towards the Elimination of Viral Hepatitis. Pathogens. 2022;11(6). [PubMed ID: 35745480]. [PubMed Central ID: PMC9228079]. https://doi.org/10.3390/pathogens11060626.
-
45.
Pourkarim M, Van Espen L, Thijssen M, Van Ranst M, Pourkarim MR. How adequate social media management supports the viral Hepatitis elimination program. Hepat Mon. 2018;18(5). https://doi.org/10.5812/hepatmon.69791.